ROBERTO SOZZI: Open Payments
NPI 1326160128 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,615 in 60 payments from 13 companies in 2025. Trend: 2023 $1,884 · 2024 $1,260 · 2025 $1,615
Food & beverage: $1,615
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $519 |
| Janssen Pharmaceuticals, Inc | 6 | $205 |
| Axsome Therapeutics, Inc. | 7 | $166 |
| E.R. Squibb & Sons, L.L.C. | 5 | $133 |
| Teva Pharmaceuticals USA, Inc. | 4 | $126 |
| Lundbeck LLC | 5 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
| Alkermes, Inc. | 2 | $62 |
| Luye Pharma (USA) Ltd. | 2 | $54 |
Products named: VRAYLAR, REXULTI, Auvelity, UZEDY, INVEGA SUSTENNA, SPRAVATO, CAPLYTA, ARISTADA.
Industry payments across NJ — which companies pay providers there.
